Michael Heltzen
CIK: 0002030840
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EXOZYMES INC.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 26, 2026EXOZ
EXOZYMES INC.
Purchase(P)Direct4 shares at avg. $7.58$30.32 - Aug 26, 2026EXOZ
EXOZYMES INC.
Purchase(P)Direct251 shares at avg. $7.35$2K - Aug 26, 2026EXOZ
EXOZYMES INC.
Purchase(P)Direct250 shares at avg. $7.60$2K - Aug 25, 2026EXOZ
EXOZYMES INC.
Purchase(P)Direct250 shares at avg. $7.52$2K - Aug 25, 2026EXOZ
EXOZYMES INC.
Purchase(P)Direct100 shares at avg. $7.50$750 - Aug 19, 2026EXOZ
EXOZYMES INC.
Award(A)Direct8.8K shares at avg. $6.40$57K - Jul 2, 2025EXOZ
EXOZYMES INC.
Purchase(P)Direct1K shares at avg. $10.22$11K - Jun 17, 2025EXOZ
EXOZYMES INC.
Award(A)DirectStock Options for Common Stock
235.8K shares- - Jan 17, 2025IZTC
Invizyne Technologies Inc
Purchase(P)Direct1.8K shares at avg. $10.78$19K - Jan 16, 2025IZTC
Invizyne Technologies Inc
Purchase(P)Direct121 shares at avg. $10.72$1K - Nov 15, 2024IZTC
Invizyne Technologies Inc
Purchase(P)Direct2K shares at avg. $11.10$22K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 26, 2026 | EXOZ EXOZYMES INC. | Purchase(P) | 4 | $7.58 | $30 | Direct |
| Aug 26, 2026 | EXOZ EXOZYMES INC. | Purchase(P) | 251 | $7.35 | $1,845 | Direct |
| Aug 26, 2026 | EXOZ EXOZYMES INC. | Purchase(P) | 250 | $7.60 | $1,900 | Direct |
| Aug 25, 2026 | EXOZ EXOZYMES INC. | Purchase(P) | 250 | $7.52 | $1,880 | Direct |
| Aug 25, 2026 | EXOZ EXOZYMES INC. | Purchase(P) | 100 | $7.50 | $750 | Direct |
| Aug 19, 2026 | EXOZ EXOZYMES INC. | Award(A) | 8,841 | $6.40 | $56,582 | Direct |
| Jul 2, 2025 | EXOZ EXOZYMES INC. | Purchase(P) | 1,040 | $10.22 | $10,629 | Direct |
| Jun 17, 2025 | EXOZ EXOZYMES INC. | Award(A) Stock Options for Common Stock | 235,817 | - | - | Direct |
| Jan 17, 2025 |  IZTC Invizyne Technologies Inc | Purchase(P) | 1,767 | $10.78 | $19,048 | Direct |
| Jan 16, 2025 | IZTC Invizyne Technologies Inc | Purchase(P) | 121 | $10.72 | $1,297 | Direct |
| Nov 15, 2024 | IZTC Invizyne Technologies Inc | Purchase(P) | 1,984 | $11.10 | $22,022 | Direct |
1-11 of 11 transactions
About Heltzen Michael
Heltzen Michael (SEC CIK 0002030840) files insider reports with the SEC as Chief Executive Officer of EXOZYMES INC. (EXOZ).
Signal8 holds 6 ownership filings by Heltzen Michael (1 Form 3, 5 Form 4), filed between Nov 18, 2024 and Sep 2, 2026. Those filings report 11 transactions, from Nov 15, 2024 to Aug 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Heltzen Michael's filings is in MONROVIA, CA.
Recent filings by Heltzen Michael
- Aug 26, 2026: Open-market purchases of EXOZ shares (3 lines, Form 4, code P).
- Aug 25, 2026: Open-market purchases of EXOZ shares (2 lines, Form 4, code P).
- Aug 19, 2026: Grant or award of EXOZ shares (Form 4, code A).
- Jul 2, 2025: Open-market purchase of EXOZ shares (Form 4, code P).
- Jun 17, 2025: Grant or award of EXOZ derivative securities (Form 4, code A).
Other insiders filing for EXOZYMES INC. (EXOZ)
- Perriman Damien Alan, Chief Commercial Officer
- Korman Tyler Paz, Chief Scientific Officer
- Rayo Edgardo Javier, Director
- MARLETT CHRISTOPHER A, Director
- Lalonde James Joseph, Director
- DIGIANDOMENICO ANTHONY, Director